Indivior Share Discussion Threads

[dealy] 28/4/2021 11:53

This conforms with one of my favorite expressions: No New News

[la forge] 28/4/2021 11:15

Indivior says US filings "administrative", no new Suboxone settlements

Wed, 28th Apr 2021 10:47
Alliance News

(Alliance News) - Indivior PLC on Wednesday said recent US state filings made in relation to settlements are just "administrative in nature" and reflect previously struck agreements.

The pharmaceutical firm noted several US states have filed announcements on agreements with Indivior in relation to its Suboxone film.

"The various state settlement agreements being announced this week are administrative in nature, and simply formalize the individual state settlements which were previously agreed to in principle as part of the July 2020 criminal and civil resolution between Indivior and the states," the company said.

"As such, there is no new financial or legal obligation that has arisen. The company was pleased to put those issues behind it in 2020 and remains focused on realizing its patient-focused Vision and fulfilling its compliance commitments."

In mid-July, Indivior agreed to part with USD600 million to resolve fraud charges with the US Justice Department in relation to Suboxone.

Indivior shares were 2.5% higher at 146.20 pence each in London on Wednesday morning.

By Eric Cunha; [e-mail]

[waldron] 28/4/2021 07:09

28 April 2021

Statement re: State Announcements

In response to various States Attorney General's recent announcements regarding SUBOXONE (R) (buprenorphine and naloxone ) Film settlements, Indivior made the following statement:

-- The various state settlement agreements being announced this week are administrative in nature, and simply formalize the individual state settlements which were previously agreed to in principle as part of the July 2020 criminal and civil resolution between Indivior and the states (and the federal government). As such, there is no new financial or legal obligation that has arisen. The Company was pleased to put those issues behind it in 2020 and remains focused on realizing its patient-focused Vision and fulfilling its compliance commitments.

The Company will have no further comment on this matter.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

[waldron] 21/4/2021 14:24

[United Kingdom] INDIVIOR PLC (INDV)

Real-time Estimate Quote. Real-time Estimate Cboe Europe - 04/21 02:23:27 pm

143.1 GBX +6.00%

[gregmorg] 19/4/2021 18:08

So Shaun takes one for the team and then gets screwed over by shareholders as well!!
But not with my vote1 By taking the fall as the ultimate boss he saved shareholders a lot of money and grief. The decision and sentencing handed down clearly highlighted this at the time.

[waldron] 19/4/2021 17:07

the sunday times


Jailed Indivior boss Shaun Thaxter faces battle to keep pay
Investor advisory group calls for drug company to claw back salary and share options
Alex Ralph
Monday April 19 2021, 12.01am BST, The Times


Last year the chief executive of Indivior was jailed after a investigation in the United States into the marketing of the drugs company’s blockbuster opioid
addiction treatment.

Shaun Thaxter is due to be released next month, but attempts by the British-born businessman to begin to rebuild his life and career are facing an instant challenge. Indivior is braced for a possible shareholder revolt over Thaxter’s exit pay and “good leaver” status at May’s annual meeting.

Thaxter, 53, was sentenced in October to six months’ imprisonment after he pleaded guilty in June to “causing the introduction into interstate commerce” of Suboxone Film, which had misbranded safety information. He stepped down from the FTSE 250 company days before his guilty plea, with his “life’s work” in tatters.

[youngers] 19/4/2021 16:32

Strong day on no news here? With legal issues resolved this looks primed for a takeover?

[waldron] 07/4/2021 10:26

aye

looking positive

if it breaks thru the 134.20p resistence the next might come into sight ar 149p
as we move towards the beginning of May

[sarkasm] 07/4/2021 09:55

Feel that headline incorrect due to translation error from french

Should haVE READ

Turnround in sight

[waldron] 31/3/2021 19:29

The 2021 AGM will be held on Thursday 6 May 2021 at 3.00pm.

[waldron] 31/3/2021 19:28

Annual Report and Notice of Annual General Meeting

The Company has today posted or made available to shareholders the following documents:

- Annual Report and Accounts for the year ended December 31, 2020 (the '2020 Annual Report');

- Notice of 2021 Annual General Meeting ('AGM')
; and
- Form of Proxy for the AGM.

In accordance with LR 9.6.1, a copy of each of these documents has been submitted to the FCA and will shortly be available for inspection at .

The 2020 Annual Report and Notice of AGM can also be viewed on the Company's website at www.indivior.com/annual-reports/ and www.indivior.com/shareholders/shareholder-communications/ .

The Appendix to this announcement contains information which has been extracted from the 2020 Annual Report for purposes of compliance with the FCA's Disclosure Guidance and Transparency Rules and should be read together with the Company's Final Results announcement released on February 18, 2021. Together these constitute the material required by Disclosure Guidance and Transparency Rule 6.3.5 which is required to be communicated to the media in full unedited text through a Regulatory Information Service.

This announcement is not a substitute for reading the full Annual Report and Accounts. Page numbers and cross references in the extracted information refer to page numbers and cross references in the 2020 Annual Report.

AGM meeting arrangements

The 2021 AGM will be held on Thursday 6 May 2021 at 3.00pm.


Due to the current COVID-19 restrictions, the AGM will be held at the Company's offices with a limited number of Company representatives attending to ensure that a valid meeting is held. Other shareholders will not be permitted to attend the AGM in person and shareholders are therefore asked to appoint the Chair of the meeting as their proxy. Arrangements have been made to allow shareholders to join the meeting online, further details can be found in the Notice of Meeting. The Board understands that the AGM is an important event in the corporate calendar and is committed to returning to an open AGM format in future years when COVID-19 restrictions are eased.

[steeplejack] 25/3/2021 11:21

Review in todays Times business section commenting on Scopia appointment to board.Just a summation of recent history really.

[gregmorg] 24/3/2021 15:11

After all activist Share holders are only interested in total return and in this lifetime!

[gregmorg] 24/3/2021 10:08

Intriguing management strategic announcement. Obviously the team put together by Scopia assumes very strong cash flows from future revenues and a strategic team is being put in place to guide /direct/build. As a 16.9% shareholder and associating itself via these appointments and tie up via the future intended enhanced build up and direction of Indivior , Scopia obviously intends to enhance its shareholding over time. Enhancing acquisitions possible over time is my guess. Will it all work - we will see.

I ask myself is this good news or bad news. Well, I don't see that it's bad news so I guess it must be good news! Jury will decide.

[gregmorg] 24/3/2021 09:16

Re Scopia move-“AND̶1;?

[waldron] 15/3/2021 13:32

perhaps next resistence at 134.20p

[waldron] 15/3/2021 13:30

(MT Newswires) -- S&P Global Ratings on Thursday affirmed Indivior's (INDV.L) B long-term rating, but revised the outlook to stable from negative, as it resolved major uncertainties related to litigation and performed stronger than expected in 2020.

The US-based pharmaceuticals company reached a $600 million settlement with the US Department of Justice and a $50 million settlement with Reckitt Benckiser (RB.L), and its cash balance of $858 million on Dec. 31, 2020, is expected to support the payments through 2027.

Meanwhile, the company's volume growth of its Sublocade injection and remaining market share of Suboxone film will generate healthy free cash flow by 2023.

"We think revenue declines in recent years are likely to stabilize in 2021, and revenue should grow in 2022 and 2023," S&P said.

Indivior's shares fell over 3% at the close of trading on Thursday.

Price (GBP): £120.00, Change: £-3.90, Percent Change: -3.15%

[dealy] 15/3/2021 13:23

not sure why this has been a laggard in recent weeks. net cash position is very high, bad events behind it now.

[gregmorg] 02/3/2021 14:50

Well, I guess it’s important for directors to be incentivised and have skin in the game although I am not sure I was asked to give them some of my skin! Having said that, at least in terms of timing it tells you the executives want to be fully on board which points to a better share price future-- in theory, I accept!

[waldron] 26/2/2021 19:13

THE WISH LIST GIVING BOXES,Supports and Resistences to determine channels and trends together with broker targets which might of course make you smile or and smirk

100 to 110p
110 to 120p
120 to 130p$$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$
130 to 140p
140 to 150p
150 to 160p
160 to 170p
170 to 180p
180 to 190p Citi target 185p
190 to 200p Jefferies target 200p





DECEMBER END 2019 GIVES 39p which puts us into the 30 to 40p BOX again

December 2020 ends at 108.80p

January 2021 ends at 137.35p

[waldron] 20/2/2021 09:21

[United Kingdom] INDIVIOR (INDV)

Delayed Quote. Delayed London Stock Exchange - 02/19 04:35:13 pm

127.6 GBX -8.40%

[waldron] 20/2/2021 09:20

THE WISH LIST GIVING BOXES,Supports and Resistences to determine channels and trends together with broker targets which might of course make you smile or and smirk

100 to 110p
110 to 120p
120 to 130p$$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$
130 to 140p
140 to 150p
150 to 160p
160 to 170p
170 to 180p
180 to 190p Citi target 185p
190 to 200p Jefferies target 200p





DECEMBER END 2019 GIVES 39p which puts us into the 30 to 40p BOX again

December 2020 ends at 108.80p

January 2021 ends at 137.35p

February 2021 ends at 128.10p

[baddeal] 19/2/2021 17:39

Slightly surprised at the weakness on the results but guess it's had a good run. Still plenty of upside imo

[waldron] 18/2/2021 16:27

Proactiveinvestors


Philip Whiterow

08:34 Thu 18 Feb 2021

Follow Philip on:
Investor deep dive

Symphony Environmental makes progress in battle against COVID-19
read more >
viewIndivior PLC
Indivior in red after legal settlements take toll

Losses for the year were US$173mln with a US$14mln deficit in the final three months
Indivior PLC -
Suboxone's market share is falling rapidly

Indivior PLC (LON:INDV) posted an improvement in sales in the final quarter of 2020 as Sublocade, its injectable, extended-release opioid dependency treatment, picked up momentum.

The drug group is trying to build sales of Sublocade to offset a steady decline by its predecessor Suboxone, which has now come off patent.

Revenues for the year to end-December fell 18% to US$647mln though there was a 39% jump in the final quarter as sales of Sublocade rose 18%.

Losses for the year were US$173mln with a US$14mln deficit in the final three months.

During the year, Indivior settled outstanding legal cases with the US Department of Justice and former parent Reckitt Benckiser and Indivior took one-off charges of US$244mln in the 2020 numbers.

Mark Crossley, chief executive, said that given the problems related to the coronavirus pandemic he was 'delighted' with the numbers.

“Critically, we materially de-risked the business with resolution of the DOJ and RB matters and we took decisive strategic alignment actions which place Indivior on a clear path towards realizing the transformational potential of Sublocade.

“Accelerating the growth of Sublocade remains the biggest potential driver of value creation.“

Indivior’s base case assumptions for 2021 are for net revenues to rise to US$625mln with Sublocade net revenues of between US185mln and $210mln (2020: US$130mln).